Morgan Stanley Ginkgo Bioworks Holdings, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 17, 2024	SELL	$0.28 - $1.16 $12.1 Million - $50 Million	-43,072,251 Reduced 87.77%	5,999,010 $1.98 Million
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $12.1 Million - $50 Million	-43,072,251 Reduced 87.77%	5,999,010 $1.98 Million
Q1 2024 Oct 17, 2024	BUY	$1.06 - $1.67 $45.7 Million - $71.9 Million	43,072,251 Added 717.99%	49,071,261 $56.9 Million
Q1 2024 Aug 16, 2024	BUY	$1.06 - $1.67 $114,948 - $181,098	108,442 Added 0.22%	49,071,261 $56.9 Million
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $114,948 - $181,098	108,442 Added 0.22%	49,071,261 $56.9 Million
Q4 2023 Aug 16, 2024	BUY	$1.26 - $1.79 $54.1 Million - $76.9 Million	42,963,809 Added 716.18%	48,962,819 $82.7 Million
Q4 2023 Feb 13, 2024	SELL	$1.26 - $1.79 $1.01 Million - $1.44 Million	-804,601 Reduced 1.62%	48,962,819 $82.7 Million
Q3 2023 Nov 15, 2023	BUY	$1.61 - $2.54 $2.75 Million - $4.33 Million	1,706,002 Added 3.55%	49,767,420 $90.1 Million
Q2 2023 Aug 14, 2023	SELL	$1.14 - $1.95 $12.5 Million - $21.4 Million	-10,979,001 Reduced 18.6%	48,061,418 $89.4 Million
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $9.55 Million - $17.4 Million	7,956,169 Added 15.57%	59,040,419 $78.5 Million
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $5.15 Million - $11.1 Million	-3,159,755 Reduced 5.83%	51,084,250 $86.3 Million
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $11 Million - $56.2 Million	15,030,976 Added 38.33%	54,244,005 $169 Million
Q2 2022 Oct 27, 2022	BUY	$2.2 - $4.2 $31.3 Million - $59.8 Million	14,233,562 Added 56.98%	39,213,029 $93.3 Million
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $31.3 Million - $59.8 Million	14,233,562 Added 56.98%	39,213,029 $93.3 Million
Q1 2022 Oct 27, 2022	SELL	$2.83 - $8.69 $40.3 Million - $124 Million	-14,233,562 Reduced 36.3%	24,979,467 $101 Million
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $29.6 Million - $90.8 Million	10,444,491 Added 71.86%	24,979,467 $101 Million
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $27.1 Million - $48.6 Million	3,260,553 Added 28.92%	14,534,976 $121 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $103 Million - $150 Million	11,274,423 New	11,274,423 $131 Million

Others Institutions Holding DNA

# of Institutions

Shares Held

48.1M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

42M
Shares

$334 Million
0.0% of portfolio
Titleist Asset Management, Ltd. San Antonio, TX

2.31M
Shares

$18.4 Million
0.92% of portfolio
Putnam Investments LLC Boston, MA

1.5M
Shares

$11.9 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.15M
Shares

$9.11 Million
0.0% of portfolio
Benjamin F. Edwards & Company, Inc. St. Louis, MO

235K
Shares

$1.87 Million
0.0% of portfolio

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account